Medicofarma Biotech (WAR:MDB) COGS-to-Revenue : 0.08 (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Medicofarma Biotech COGS-to-Revenue?

Medicofarma Biotech's Cost of Goods Sold for the three months ended in Mar. 2024 was zł0.07 Mil. Its Revenue for the three months ended in Mar. 2024 was zł0.87 Mil.

Medicofarma Biotech's COGS to Revenue for the three months ended in Mar. 2024 was 0.08.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Medicofarma Biotech's Gross Margin % for the three months ended in Mar. 2024 was 92.20%.

Medicofarma Biotech COGS-to-Revenue Historical Data

The historical data trend for Medicofarma Biotech's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicofarma Biotech COGS-to-Revenue Chart

Medicofarma Biotech Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

Get a 7-Day Free Trial

0.73

0.74

0.79

0.58

0.75

Medicofarma Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.21	0.14	0.44	0.17	0.08

Medicofarma Biotech COGS-to-Revenue Calculation

Medicofarma Biotech's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	3.192	/	4.252
	=	0.75

Medicofarma Biotech's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.068	/	0.872
	=	0.08

Medicofarma Biotech (WAR:MDB) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Medicofarma Biotech's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.068 / 0.872
	=	92.20 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Medicofarma Biotech COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Medicofarma Biotech's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicofarma Biotech (WAR:MDB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicofarma Biotech SA (WAR:MDB) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

ul. Soko?owska 9 lok. U19, Warsaw, POL, 01-142

Website

https://www.medicofarma.pl

Medicofarma Biotech SA operates in the pharmaceutical industry. The company specializes in contract manufacturing of medical devices, medicinal products and dietary supplements. The business is spread across Austria, Czech Republic, Spain, Ireland, Canada, Germany, Norway, Sweden, Great Britain, and Italy.